Jacob Chacko, PRESIDENT AND CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 80,000 shares at $12.30 ($979K) on 2024-02-07, disclosed to the SEC on 2024-02-08.
Open-market sale of $979k ORIC by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.12 | 13,958 | $169K | 17.3% |
| 2 | $12.12 | 13,958 | $169K | 17.3% |
| 3 | $12.30 | 26,042 | $320K | 32.7% |
| 4 | $12.30 | 26,042 | $320K | 32.7% |
| Total | $12.24 avg | 80,000 | $979K | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |